[1]罗作明,吴华.PET代谢显像剂11C-乙酸盐在临床中的应用[J].国际放射医学核医学杂志,2007,31(1):25-27.
 LUO Zuo-ming,WU Hua.Clinical application of 11C-acetate PET metabolism imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(1):25-27.
点击复制

PET代谢显像剂11C-乙酸盐在临床中的应用(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
31
期数:
2007年第1期
页码:
25-27
栏目:
临床核医学
出版日期:
1900-01-01

文章信息/Info

Title:
Clinical application of 11C-acetate PET metabolism imaging
作者:
罗作明 吴华
361003 福建, 福建医科大学附属厦门市第一医院核医学科、闽南PET中心
Author(s):
LUO Zuo-ming WU Hua
Department of Nuclear Medicine and Minnan PET Center, Xiamen First Hospital, Fujian Medical University, Xiamen 361003, China
关键词:
乙酸盐类前列腺肿瘤肝肿瘤心肌显像体层摄影术发射型计算机对比研究
Keywords:
AcetatesProstatic neoplasmsLiver neoplasmsMyocardial imagingTomography emission-computedComparative study
分类号:
R817.4
摘要:
18F-氟脱氧葡萄糖(18F-FDG)是一种最常用的肿瘤正电子显像剂,但对于炎性病变鉴别困难,易得出肿瘤假阳性诊断结果。PET代谢显像剂11C-乙酸能够弥补。18F-FDGPET的某些不足,已用于各类肿瘤的诊断及鉴别诊断,特别是在肝癌以及前列腺癌等的诊断及鉴别诊断方面明显优于18F-FDGPET;基于11C-乙酸盐的特性,也常被用于心肌血流和灌注显像。
Abstract:
18F-fluorodeoxyglueose (18F-FDG) is the most widely used PET agent for imaging tumors. However, 18F-FDG PET showed a relatively high false positive rate when it is used to differentia the malignant and benign lesions. 11C-aeetate metabolie PET may overcome some limitations of 18F-FDG PET and has elinieal potentials. It has demonstrated advantages over 18F-FDG PET in the tumors such as prostate cancer, hepatocellular carcinoma. Because of the metabolie characteristics of 11C-acetate, it may be used to assess myoeardial viability, blood flow and peffusion.

参考文献/References:

1 Fricke E, Machtens S, Hofmann M, et al. Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancerpatients. Eur J Nucl Med Mol Imaging, 2003, 30(4):607-611.
2 Sun KT, Yeatman LA, Buxton DB, et al. Simultaneous measurement of myocardial oxygen consumption and blood flow using[1-Carbon-11] acetate. J Nucl Med, 1998, 39(2):272-280.
3 Sciacca RR, Akinboboye O, Chou RL, et al. Measurement of myocardial blood flow with PET using 1-11C-acetate. J Nucl Med,2001, 42(1):63-70.
4 Klein LJ, Visser FC, Knaapenl P, et al. Carbon-11-acetate as a tracer of myocardial oxygen consumption. Eur J Nucl Med,2001, 28(5):651-668.
5 Wolpers HG, Burchert W, Van den Hoff J, et al. Assessment of myocardial viability by use of 11C-acetate and positron emissiontomography. J Circular, 1997, 95(6):1417-1424.
6 Ukkonen H, Knuuti J, Katoh C, et al. Use of [11C]-acetate and [15O] O2 PET for the assessment of myocardial oxygen utilization in patients with chronic myocardial infarction. Eur J Nucl Med,2001, 28(3):334-339.
7 Gropler RJ, Gehman EM, Sampathkumaran K, et al. Comparisonof carbon-11-acetate with fluorine-18-fluorodeoxyglueose for delineating viable myoeardium by positron emission tomography. J Am Coll Cardiol, 1993, 22(6):1587-1597.
8 叶任高.内科学.第五版.北京:人民卫生出版社,2001.473-474.
9 Khan MA, Combs CS, Brunt EM, et al. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol, 2000, 32(5):792-797.
10 Ho CL, Yu SC, Yeung DW. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med, 2003, 44(2):213-221.
11 Hara T. 18F-fluomcholine:a new oncologic PET tracer. J Nucl Med, 2001, 42(12):1815-1817.
12 Oyama N, Akino H, Kanamaru H, et al. 11C-acetate PET imaging of prostate cancer. J Nucl Med, 2002, 43(2):181-186.
13 Kotzerke J, Volkmer BG, Glatting G, et al. Intraindividual comparison of 11C-acetate and 11C-choline PET for detection of metastases of prostate cancer. J Nuklearmedizin, 2003, 42(1):25-30.
14 Higashi K, Ueda Y, Matsunari I, et al.11C-acetate PET imaging of lung cancer:comparison with 18F-FDG PET and 99mTc-MIBISPET. EurJ Nucl Med Mol Imaging, 2004, 31(1):13-21.
15 Liu RS. Clinical application of 11C-acetate in oncology. Clin Positron Imaging, 2000, 3(4):185.

相似文献/References:

[1]张奇洲,李毓斌,李肖红,等.11C-乙酸盐的自动化合成影响因素的考察及质量控制[J].国际放射医学核医学杂志,2016,40(1):6.[doi:10.3760/cma.j.issn.1673-4114.2016.01.002]
 Zhang Qizhou,Li Yubin,Li Xiaohong,et al.Study of the automated synthesis influence factors and quality control of 11C-acetate[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):6.[doi:10.3760/cma.j.issn.1673-4114.2016.01.002]
[2]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
 Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[3]廖光星,冷志欣,肖国有.前列腺癌骨转移影像诊断方法研究进展[J].国际放射医学核医学杂志,2016,40(6):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
 Liao Guangxing,Leng Zhixin,Xiao Guoyou.Progress of imaging in the diagnosis of bone metastases of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
[4]刘辰,杨悦,张雪宁,等.MRI和1997年版Partin表对前列腺癌病理特征预测准确性的对比研究[J].国际放射医学核医学杂志,2015,39(2):124.[doi:10.3760/cma.j.issn.1673-4114.2015.02.005]
 Liu Chen,Yang Yue,Zhang Xuening,et al.Accuracy of MRI and 1997 edition of Partin tables in predicting the pathological features of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):124.[doi:10.3760/cma.j.issn.1673-4114.2015.02.005]
[5]王振光,王洋洋.PET/CT显像在肝细胞肝癌诊断中的研究进展[J].国际放射医学核医学杂志,2015,39(2):175.[doi:10.3760/cma.j.issn.1673-4114.2015.02.016]
 Wang Zhenguang,Wang Yangyang.The development of PET/CT imaging in the diagnosis of hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):175.[doi:10.3760/cma.j.issn.1673-4114.2015.02.016]
[6]赵雷,杨雁,孙华.自动化固相萃取法合成11C-乙酸盐的影响因素[J].国际放射医学核医学杂志,2015,39(3):224.[doi:10.3760/cma.j.issn.1673-4114.2015.03.008]
 Zhao Lei,Yang Yan,Sun Hua.Influential factors of solid-phase extraction method to automate the synthesis of 11C-acetate[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):224.[doi:10.3760/cma.j.issn.1673-4114.2015.03.008]
[7]桂继琮,刘兴党.镭-223氯化物治疗去势抵抗性前列腺癌骨转移的研究进展[J].国际放射医学核医学杂志,2015,39(3):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
 Gui Jicong,Liu Xingdang.Development in the study of radium-223 chloride for treating castration-resistant prostate carcinoma with bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
[8]张晖,段清,卓娜,等.经直肠超声引导下“6+X”点法前列腺穿刺活检诊断前列腺癌的临床价值分析[J].国际放射医学核医学杂志,2015,39(4):308.[doi:10.3760/cma.j.issn.1673-4114.2015.04.008]
 Zhang Hui,Duan Qing,Zhuo Na,et al.Meta-analysis of the diagnostic value of transrectal ultrasound-guided “6+X” points biopsy in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):308.[doi:10.3760/cma.j.issn.1673-4114.2015.04.008]
[9]张龙敏,刘爱连.前列腺癌MRI诊断技术研究进展[J].国际放射医学核医学杂志,2014,38(1):53.[doi:10.3760/cma.j.issn 1673-4114.2014.01.011]
 Zhang Longmin,Liu Ailian.Advances in MRI diagnosis of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):53.[doi:10.3760/cma.j.issn 1673-4114.2014.01.011]
[10]刘辰,杨悦,张雪宁,等.CT/MRI图像融合在前列腺癌IMRT中的应用进展[J].国际放射医学核医学杂志,2014,38(4):247.[doi:10.3760/cma.j.issn.1673-4114.2014.04.010]
 Liu Chen,Yang Yue,Zhang Xuening,et al.CT/MRI image fusion in intensity modulated radiation therapy for prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):247.[doi:10.3760/cma.j.issn.1673-4114.2014.04.010]

备注/Memo

备注/Memo:
收稿日期:2006-02-16。
通讯作者:吴华,E-mail:Wuhuaa@hotmail.com
更新日期/Last Update: 1900-01-01